Anti-angiogenic therapy combination with hypoxia-regulating agent leads to improved tumor regression
We will be attending the AACR Virtual Annual Meeting, from June 22 to 24, 2020 to present our posters featuring our capacities / platforms that support drug discovery in Immuno-Oncology.